Pathologic Complete Response After Enfortumab Vedotin Plus Pembrolizumab in Node-positive Upper Tract Urothelial Carcinoma

Kayo Kikuchi(Tokyo Women's Medical University Hospital), Toshio Takagi(Tokyo Women's Medical University Hospital), Takayuki Nakayama(Tokyo Women's Medical University Hospital), Jumpei Iizuka(Tokyo Women's Medical University Hospital), Hironori Fukuda(Tokyo Women's Medical University Hospital), Kazuhiko Yoshida(Tokyo Women's Medical University Hospital), Yoji Nagashima(Tokyo Women's Medical University Hospital), Tomoko Yamamoto(Tokyo Women's Medical University Hospital), Kana Shibusawa(Tokyo Women's Medical University Hospital), Takashi Ikeda(Tokyo Women's Medical University Hospital), Kazutaka Nakamura(Tokyo Women's Medical University Hospital), Hideki Ishida(Tokyo Women's Medical University Hospital), Yuki Kobari(Tokyo Women's Medical University Hospital)
In Vivo
April 28, 2026
Cited by 0


Related Papers